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In the previous issue of Critical Care, Dr Žuran and 
collaborators reported the results of an interesting, small-
sized, open-label study investigating the eﬀ  ects  of 
targeting diﬀ  erent levels of blood glucose with insulin in 
patients with severe sepsis [1]. As compared with a blood 
glucose target of 7 to 11  mmol/l, targeting a blood 
glucose level of 4.4 to 6.1  mmol/l increased forearm 
blood ﬂ   ow measured by the strain-gauge plethysmo-
graphy method, at 24 and 72 hours after initiation of the 
intervention. Th  ese diﬀ  erences occurred in the absence 
of detectable diﬀ   erences in hemodynamics or patient 
outcome. Th  e authors concluded that these data corro-
borate a protective eﬀ   ect on the endothelium, and 
attribute this to the amount of insulin rather than to the 
level of blood glucose control.
Žuran and colleagues’ study is an interesting clinical 
observation made in a diﬃ   cult setting of clinical practice 
treating patients with sepsis and organ failure, for which 
the authors ought to be congratulated. Th   e small sample 
size, with a trend for slightly diﬀ  erent  baseline 
characteristics, particu  larly concerning the severity of the 
shock, as well as the nonblinded nature of the study, 
however, may have played a confounding role. 
Nevertheless, if the increase in forearm ﬂ  ow is indeed 
evoked by the more intensive insulin therapy, it 
corroborates extensive data from basic research in in 
vitro cellular models [2-4] and from in vivo animal 
research [5,6], as well as observations in healthy subjects 
[7,8] and on tissue samples obtained from patients in the 
proof-of-concept study on blood glucose control 
performed in Leuven [9,10]. Together, these previous 
data suggested that insulin signaling mediates a direct 
and/or indirect protection of the endothelium and the 
cardiovascular system, but that this is antagonized by 
concomitant pronounced hyperglycemia.
Th  e antagonistic eﬀ  ect between insulin signaling and 
hyperglycemia on inﬂ   ammation and blood ﬂ   ow is an 
interesting one, which is important to take into account 
when analyzing results of studies on the topic. In this 
light, the weak correlation in the current study by Žuran 
and colleagues between the forearm ﬂ  ow and the insulin 
doses, largely explained by one outlier, does not suﬃ   ce to 
conclude that the concomitant prevention of hyper-
glycemia was not important, as both higher insulin doses 
and lower blood glucose levels were brought about 
simultaneously. Furthermore, it may be that a certain 
threshold of hyperglycemia needs to be avoided in order 
for insulin to exert a protective eﬀ  ect on the endothelium. 
In Žuran and colleagues’ study, the large spread of the 
achieved blood glucose levels at all studied time points, 
and the very important overlap between the two study 
arms, does not allow one to deﬁ   ne such a threshold. 
Indeed, the studied intervention was a complex one; an 
insulin regimen targeting lower blood glucose levels, and 
thus a weak correlation with the forearm ﬂ  ow of one 
aspect of this complex intervention (insulin dose) and the 
absence of a correlation with the other aspect of this 
complex intervention (blood glucose level achieved) – 
the latter quite diﬃ   cult to quantify accurately over time – 
does not allow one to discard the importance of one 
aspect over the other.
Abstract
A small study in patients with severe sepsis suggested 
that insulin infused to normalize blood glucose levels 
increased forearm fl  ow. This clinical observation 
supports the eff  ect of insulin on the endothelium, 
as previously shown by in vitro studies and by in 
vivo animal models of critical illness, but the clinical 
consequences remain unclear.
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© 2010 BioMed Central LtdTh   e clinical relevance of a reduction in forearm ﬂ  ow in 
patients with severe sepsis with intensiﬁ  ed  insulin 
therapy remains unclear, as recognized adequately by the 
authors. Firstly, one could question the relevance of the 
small observed eﬀ   ect size on forearm ﬂ   ow and the 
apparently transient nature. Indeed, the patients in the 
two groups remained hemodynamically comparable 
throughout the study and did not require diﬀ  erent 
amounts of ﬂ  uids, vasopressors or inotropes; and neither 
did they reveal any diﬀ  erence in organ function. Secondly, 
it remains obscure whether a change in forearm ﬂ  ow is 
giving any information on the vital organ perfusion and 
oxygenation. Indeed, an increase in blood ﬂ  ow to the 
skeletal muscle may either reﬂ  ect an overall increase of 
ﬂ   ow to the body or instead may hint towards a steel 
phenomenon, hiding a decrease of ﬂ   ow to the vital 
organs. Th  e clinical implications of these two possible 
interpretations are entirely diﬀ  erent, as they may range 
from a beneﬁ   cial protection of an important organ 
system to a deleterious silent risk for instability.
Despite these additional questions raised by the study 
presented by Žuran and colleagues, the elegant demon-
stration of the diﬀ  erence in forearm ﬂ  ow does indicate 
that the vasculature may indeed be aﬀ  ected  by 
intensiﬁ   ed insulin therapy. Th   e observation nicely 
corroborates previous basic science data, and therefore 
requires further detailed investigation. Understanding 
the under  lying mechanisms and the clinical conse-
quences will provide further insight into the controversy 
that currently surrounds the concept of glucose control 
in ICU patients [11].
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